𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cisplatin-based chemotherapy for the treatment of advanced transitional-cell carcinoma of the urinary tract — a preliminary report

✍ Scribed by Ming-Huei Lee; M. T. Chen; K. K. Chen; Alex T. L. Lin; Y. H. Lee; L-M Lee; Y-M Chang; Luke S. Chang; J. M. Liu; R. K. Hsieh; P. M. Chen

Publisher
Springer
Year
1992
Tongue
English
Weight
407 KB
Volume
30
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine and carboplatin in advanced
Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract : An alternative therapy
✍ Miquel Nogué-Aliguer; Joan Carles; Antonio Arrivi; Oscar Juan; Lorenzo Alonso; A 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

## Abstract ## BACKGROUND Cisplatin‐based combinations are considered to be the standard treatment for advanced transitional cell carcinoma (TCC) of the urothelium. Many of the patients are elderly with concomitant diseases or impaired renal function. We studied the tolerance and activity of the g

A phase II study of mitoguazone and vinb
A phase II study of mitoguazone and vinblastine in advanced transitional cell carcinoma of the urinary tract
✍ John T. Barrett; Bruno Orofiamma; Janardan D. Khandekar; Paul P. Carbone; Robert 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 330 KB 👁 2 views

This is a comparative study to evaluate response rate to mitoguazone (MGBG) and vinblastine (VLB) in 52 evaluable patients with advanced transitional cell carcinoma of the urinary tract. Of 38 patients with measurable disease, two of 18 (11%) on MGBG had partial remission (95% confidence interval: 0

A study of cyclophosphamide, adriamycin,
A study of cyclophosphamide, adriamycin, cis-platinum, and methotrexate in advanced transitional cell carcinoma of the urinary tract
✍ Dennis L. Citrin; Tom F. Hogan; Tom E. Davis 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 2 views

Twenty patients with locally advanced and/or metastatic transitional cell cancer of the urinary tract were treated with cyclophosphamide 500 mg/m2, Adriamycin (doxorubicin) 40 mg/m2 and cis-platinum (CDDP) 40 mg/m2 given every three weeks for 2 cycles, alternating with methotrexate 40 mg/m2 weekly f

Carboplatin-based versus cisplatin-based
Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma
✍ Joaquim Bellmunt; Antoni Ribas; Natalia Eres; Joan Albanell; Concepción Almanza; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 2 views

therapeutic advantage over the cisplatin-based regimen M-VAC (methotrexate, Concepcio ´n Almanza, M.D. vinblastine, doxorubicin, and cisplatin) in the treatment of patients with surgically Begon ˜a Bermejo, M.D. incurable advanced bladder carcinoma. Luis-Alfonso Sole ´, M.D. ## METHODS. Patients w